跳至主要内容
临床试验/CTRI/2018/07/015127
CTRI/2018/07/015127尚未招募不适用

A randomized control trial to assess the effectiveness of nurse initiated guidelines on management of hypernatremia and diabetes DI among postoperative patients of sellar/ suprasellar tumour surgery.

Hemlata1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2018年1月8日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
2. Clinical manifestations of DI

研究概览

简要总结

It is an randomized control trial will be done on the post operative patient of sellar and suprasellar tumours in the month of july- august 2018, In this trial 25 patient randomized for the control group and 25 patients randomized for the experimental group to see the effect of the nurse initiated guidelines on management of hypernatremia and diabetes insipidus.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Not Applicable

入排标准

年龄范围
11.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • All postoperative patients with sellar and suprasellar tumour admitted in neurosurgical units of Nehru Hospital, PGIMER, Chandigarh during July-September
  • Participant who will be willing to participate in the study.

排除标准

  • Patient having known case of: -Diabetes insipidus -Diseases causing fluid electrolyte imbalance like CRF/CKD/Renal disorder
  • The post operative patient with sellar and suprasellar tumour who are not willing to participate.

结局指标

主要结局

2. Clinical manifestations of DI

时间窗: 2 months

Hypernatremia

时间窗: 2 months

1. Number of episodes

时间窗: 2 months

Diabetes insipidus

时间窗: 2 months

2. Severity

时间窗: 2 months

次要结局

  • Secondary outcome variables(-Duration of hospital stay)

研究者

发起方
Hemlata
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验